FORM 4
( ) Check this box if no longer
subject to Section 16. Form 4
or Form 5 obligations may continue.
See Instruction 1(b).
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION _____________________
WASHINGTON, D.C. 20549 | OMB APPROVAL |
|---------------------|
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP |OMB NUMBER: 3235-0287|
|EXPIRES: |
| DECEMBER 31, 2001 |
Filed pursuant to Section 16(a) of the |ESTIMATED AVERAGE |
Securities Exchange Act of 1934, |BURDEN HOURS |
Section 17(a) of the Public Utility |PER RESPONSE ... 0.5 |
Holding Company Act of 1935 |_____________________|
or Section 30(f) of the Investment
Company Act of 1940
---------------------------------------------------------------------------
1. Name and Address of Reporting Person
Tomlin Merrell M.
-----------------------------------------------------------------------
(Last) (First) (Middle)
c/o Rayovac Corporation, 601 Rayovac Drive
-----------------------------------------------------------------------
(Street)
Madison Wisconsin 53711
-----------------------------------------------------------------------
(City) (State) (Zip)
---------------------------------------------------------------------------
2. Issuer Name and Ticker or Trading Symbol
Rayovac Corporation (ROV)
---------------------------------------------------------------------------
3. I.R.S. Identification Number of Reporting Person, if an entity
(Voluntary)
---------------------------------------------------------------------------
4. Statement for Month/Year
June/2001
---------------------------------------------------------------------------
5. If Amendment, Date of Original (Month/Year)
---------------------------------------------------------------------------
6. Relationship of Reporting Person(s) to Issuer (Check all applicable)
( ) Director
( ) 10% Owner
(X ) Officer (give title below)
( ) Other (specify title below)
Executive Vice President of Sales
---------------------------------------------------------------------------
7. Individual, or Joint/Group Filing (Check Applicable Line)
(X ) Form filed by One Reporting Person
( ) Form filed by More than One Reporting Person
---------------------------------------------------------------------------
===========================================================================
TABLE I - NON-DERIVATIVE SECURITIES ACQUIRED, DISPOSED OF,
OR BENEFICIALLY OWNED
---------------------------------------------------------------------------
1. Title of Security (Instr. 3)
A. Common Stock, par value $.01 per share
B. Common Stock, par value $.01 per share
---------------------------------------------------------------------------
2. Transaction Date (Month/Day/Year)
A. 6/20/2001 (1)
B. 6/20/2001 (1)
---------------------------------------------------------------------------
3. Transaction Code (Instr. 8)
A. M
B. S
---------------------------------------------------------------------------
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5)
A. 65,184 shares acquired upon the exercise of options at an exercise
price of $4.39 per share (A)
B. 68,700 shares sold at $19.50 per share (D)(2)
---------------------------------------------------------------------------
5. Amount of Securities Beneficially Owned at End of Month
(Instr. 3 and 4)
32,700
---------------------------------------------------------------------------
6. Ownership Form: Direct(D) or Indirect(I) (Instr. 4)
(D)
---------------------------------------------------------------------------
7. Nature of Indirect Beneficial Ownership (Instr. 4)
Not Applicable.
---------------------------------------------------------------------------
Reminder: Report on a separate line for each class of securities
beneficially owned directly or indirectly.
===========================================================================
TABLE II - DERIVATIVE SECURITIES ACQUIRED, DISPOSED OF, OR BENEFICIALLY
OWNED
(E.G., PUTS, CALLS, WARRANTS, OPTIONS, CONVERTIBLE SECURITIES)
---------------------------------------------------------------------------
1. Title of Derivative Security (Instr. 3)
Employee Stock Option (Right to Buy)
---------------------------------------------------------------------------
2. Conversion or Exercise Price of Derivative Security
$4.39
---------------------------------------------------------------------------
3. Transaction Date (Month/Day/Year)
6/20/2001 (1)
---------------------------------------------------------------------------
4. Transaction Code (Instr. 8)
M
---------------------------------------------------------------------------
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
Exercised option to purchase 65,184 shares of common stock (D)
---------------------------------------------------------------------------
6. Date Exercisable and Expiration Date (Month/Day/Year)
See Footnote (3)
---------------------------------------------------------------------------
7. Title and Amount of Underlying Securities (Instr. 3 and 4)
Common Stock; 65,184 shares
---------------------------------------------------------------------------
8. Price of Derivative Securities (Instr. 5)
---------------------------------------------------------------------------
9. Number of Derivative Securities Beneficially Owned at End of Month
(Instr. 4)
48,763
---------------------------------------------------------------------------
10. Ownership Form of Derivative Security: Direct(D) or Indirect(I)
(Instr. 4)
(D)
---------------------------------------------------------------------------
11. Nature of Indirect Beneficial Ownership (Instr. 4)
Not applicable.
----------------------------------------------------------------------------
EXPLANATION OF RESPONSES:
(1) On June 20, 2001, the reporting person entered into a Purchase
Agreement between Rayovac Corporation, the underwriters named in Schedule A
thereto and the selling shareholders named in Schedule B thereto with
respect to sales of common stock of Rayovac Corporation, including the
transactions reported herein. The closing of the transactions contemplated
by the Purchase Agreement occurred on June 26, 2001.
(2) The price per share does not reflect underwriting discounts of $.925
per share.
(3) The option vests and becomes exercisable in equal annual installments
over a five-year period that commenced October 1, 1996. The option expires
on October 1, 2006.
/s/ James T. Lucke, as attorney-in-fact July 3, 2001
--------------------------------------------- -----------------------
** SIGNATURE OF REPORTING PERSON DATE
-----------------------------
** INTENTIONAL MISSTATEMENTS OR OMISSIONS OF FACTS CONSTITUTE FEDERAL
CRIMINAL VIOLATIONS. SEE 18 U.S.C. 1001 AND 15 U.S.C. 78ff(a).
NOTE: FILE THREE COPIES OF THIS FORM, ONE OF WHICH MUST BE MANUALLY
SIGNED. IF SPACE IS INSUFFICIENT, SEE INSTRUCTION 6 FOR PROCEDURE.
POTENTIAL PERSONS WHO ARE TO RESPOND TO THE COLLECTION OF INFORMATION
CONTAINED IN THIS FORM ARE NOT REQUIRED TO RESPOND UNLESS THE FORM
DISPLAYS A CURRENTLY VALID OMB NUMBER.
===========================================================================